Brett Hagen

Brett Hagen has extensive work experience in finance and accounting. Brett is currently a Senior Vice President and Chief Accounting Officer (CAO) at AlloVir, starting in February 2022. Prior to that, they served as the Vice President and CAO at AlloVir from July 2020 to February 2022. Before joining AlloVir, they were the Senior Director and CAO at AlloVir from January 2019 to June 2020.

Before joining AlloVir, Hagen held various roles in finance and accounting. Brett was the Senior Director of Finance and Accounting at Eloxx Pharmaceuticals in 2018. From 2016 to 2017, they were the Vice President of Finance and Controller at Proteostasis Therapeutics, Inc. Brett was also the Controller at BIND Therapeutics from 2014 to 2016. Prior to that, they worked at Boston Private Financial Holdings as the VP and Controller of Investment Management/Wealth Advisory Segments from 2009 to 2014.

Brett'searlier work experience includes roles at The Princeton Review, BioProcessors, PwC, and the USAF. At The Princeton Review, they were a Manager of Financial Reporting and Technical Accounting in 2008. Brett served as a Controller at BioProcessors from 2007 to 2008. Hagen began their career as an Auditor at PwC from 2004 to 2007. Brett also served as a Captain in the USAF from 1997 to 2004.

Brett Hagen completed their Master of Science (M.S.) degree in Finance from Suffolk University in 2014. Prior to that, they obtained a MAcc degree in Accounting from Wright State University in the period from 2000 to 2004. Brett also attended the University of Minnesota from 1992 to 1997, but the information regarding their degree and field of study is not provided. Brett completed their high school education at Apple Valley Senior High School in 1991.